Life Science REIT PLC New Lease at Oxford Technology Park (5740Y)
04 Janeiro 2024 - 4:00AM
UK Regulatory
TIDMLABS
RNS Number : 5740Y
Life Science REIT PLC
04 January 2024
4 January 2024
LEI: 213800RG7JNX7K8F7525
Life Science REIT plc
("Life Science REIT" or the "Company")
New Lease at Oxford Technology Park
Innovation Quarter Letting to Quantum Advanced Solutions
Limited
Life Science REIT (LSE: LABS), the real estate investment trust
focused on UK life sciences properties, is pleased to announce the
letting of 5,551 sq. ft. at the Innovation Quarter ("IQ") at Oxford
Technology Park ("OTP") to Quantum Advanced Solutions Limited
("Quantum Solutions"), an expert in quantum dot sensors/materials
development and manufacturing with a range of life science and
technology clients, including Merck KGaA, Panasonic Corporation,
Nordson, Sony, Imec and the University of Oxford.
The IQ is a differentiated offering within the wider OTP campus
targeting emerging life science businesses with smaller, more
flexible space which can accommodate both wet and dry labs, offices
and light production. Covering 69,700 sq. ft., the IQ reached
practical completion in August this year; it is EPC A rated and is
on track to achieve a BREEAM Excellent certification.
Quantum Solutions provides quantum dot sensors and materials to
extend the sensitivity of silicon sensors with a wide range of
applications such as medical imaging. Established in 2017, Quantum
Solutions has been growing rapidly and has chosen Oxford for its
new facilities to be closer to existing and prospective customers.
Quantum Solutions will pay an annual rent of GBP122,122, equating
to GBP22.0 psf for ten years, with a break clause and rent review
at the end of the fifth year.
Ian Harris, Director of Asset Management at Ironstone Asset
Management, the Company's Investment Adviser, said : "This is the
second letting at the Innovation Quarter at OTP, proving the
concept that emerging life science businesses want more flexible
and more affordable space. OTP's location, close to the academic
and research institutions of Oxford and its proximity to Quantum
Advanced Solutions' customer base, was key to their decision to
expand with OTP."
Marat Lutfullin, CEO at Quantum Advanced Solutions said : "This
signifies a pivotal moment for Quantum Solutions, as we embark on a
significant expansion of our R&D and manufacturing efforts to
bring our sensor and materials products to an increasingly global
customer base. The modern facilities at OTP, coupled with their
flexible fit-out capabilities, provide an ideal setting for the
establishment of our unique and innovative operations. We are
honoured to be in close proximity to Oxford University and its
vibrant ecosystem."
OTP was acquired by Life Science REIT in May 2022. It now
comprises five completed buildings totalling 173,400 sq. ft. and
333,200 sq. ft. of development space. Existing occupiers at the
park include The Native Antigen Company, a developer and
manufacturer of antigens and antibodies, Oxford Gene Technology, a
provider of clinical research and diagnostic solutions, and Oxford
Ionics, a leading quantum computing business.
END
Enquiries:
+44 20 3011
Ironstone Asset Management - Investment Adviser 2160
Simon Farnsworth, Managing Director
Simon.farnsworth@ironstoneam.com
Joanna Waddingham, Head of Investor Relations
and Corporate Affairs
Joanna.Waddingham@ironstoneam.com
Link Company Matters Limited - Company Secretary
labs_cosec@linkgroup.co.uk
Panmure Gordon (UK) Limited - Joint Corporate +44 20 7886
Broker 2500
Alex Collins / Tom Scrivens
Jefferies International Limited - Joint Corporate +44 20 7029
Broker 8000
Tom Yeadon / Andrew Morris / Oliver Nott /
Harry Randall
+44 20 7397
G10 Capital Limited - AIFM 5450
Maria Baldwin
+44 20 7466
Buchanan - Financial PR 5000
Mark Court / Henry Wilson / Verity Parker
LifeSciencereit@buchanan.uk.com
Notes to editors
Life Science REIT plc is a specialist property business focused
on the UK's growing life science sector. The Company's portfolio of
assets is located across the "Golden Triangle" of research and
development hubs in Oxford, Cambridge and London's Knowledge
Quarter and its strategic vision is to become the property provider
of choice for life science companies in the UK.
Life Science REIT is addressing the acute demand-supply
imbalance for laboratory space in the "Golden Triangle", which is
characterised by low vacancy rates and prime rental increases. The
UK life science sector itself is benefiting from a buoyant
early-stage funding environment, driving demand for laboratory
space.
The Company's diverse portfolio of assets ranges from a 20-acre
science park currently under development through to fully let
buildings, with an important part of the Company's strategy being
the conversion of existing properties to laboratory space.
The Company's investment policy is focused on capital growth
whilst also providing a growing level of income.
Life Science REIT trades on the Main Market of the London Stock
Exchange under the ticker LABS.
Further information is available at
https://lifesciencereit.co.uk . To sign up for email alerts, please
visit https://lifesciencereit.co.uk/investors/ .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
UPDSSEFWDELSESF
(END) Dow Jones Newswires
January 04, 2024 02:00 ET (07:00 GMT)
Life Science Reit (LSE:LABS)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Life Science Reit (LSE:LABS)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024